Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1148/radiol.2331031188
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heverhagen, J. T.
Right arrow Articles by Hellinger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heverhagen, J. T.
Right arrow Articles by Hellinger, A.
(Radiology 2004;233:273-280.)
© RSNA, 2004

Technical Developments

Pancreatic Transplants: Noninvasive Evaluation with Secretin-augmented MR Pancreatography and MR Perfusion Measurements—Preliminary Results1

Johannes T. Heverhagen, PhD, MD, Hans-Joachim Wagner, MD, PhD, Horst Ebel, MD, Andrea L. Levine, BS, Klaus J. Klose, MD, PhD and Achim Hellinger, MD, PhD

1 From the Departments of Diagnostic Radiology (J.T.H., H.J.W., K.J.K.), Surgery (H.E.), and Nephrology (A.H.), University Hospital, Philipps University, Marburg, Germany; and Department of Radiology, Ohio State University, 645 Means Hall, 1654 Upham Dr, Columbus, OH 43210 (J.T.H., A.L.L.). Received July 26, 2003; revision requested October 9; revision received January 11, 2004; accepted February 4. Address correspondence to J.T.H. (e-mail: heverhagen@gmx.net).

Feasibility of secretin-augmented magnetic resonance (MR) pancreatography and dynamic contrast material–enhanced MR measurements for evaluation of functional status of pancreatic allografts was determined by quantifying the excretion and perfusion of the grafts. Ten patients were included prospectively before pancreatic transplantation. Dynamic T2-weighted sequences after secretin stimulation and dynamic contrast-enhanced T1-weighted gradient-echo sequences were performed. Area under the curve and maximum signal intensity–to-time ratio were determined in selected regions of interest. Biochemical parameters, Doppler ultrasonography, and/or surgery were standards for final diagnosis. Patients with normal outcome (n = 7) produced 236 mL ± 104 (standard deviation) of pancreatic juice, and patients with dysfunctional grafts (n = 3) produced 42 mL ± 25. Area under the curve and maximum signal intensity–to-time ratio provided thresholds of 0.5 and 0.3, respectively, for distinction between functional and dysfunctional grafts. Secretin-augmented MR pancreatography combined with MR perfusion measurements may aid in differentiation between patients with and those without graft dysfunction.

© RSNA, 2004

Index terms: Magnetic resonance (MR), perfusion study, 770.12144 • Pancreas, function • Pancreas, MR, 770.121411, 770.121412, 770.12143, 770.12144 • Pancreas, transplantation




This article has been cited by other articles:


Home page
 RadiologyHome page
J. T. Heverhagen
Noise Measurement and Estimation in MR Imaging Experiments
Radiology, December 1, 2007; 245(3): 638 - 639.
[Full Text] [PDF]